Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
07/1998
07/07/1998CA2133963C Novel mercaptoacetylamido pyridazo¬1,2|pyridazine, pyrazolo¬1,2|pyridazine, pyridazo¬1,2-a|¬1,2|diazepine and pyrazolo¬1,2-a|¬1,2|diazepine derivatives useful as inhibitors of enkephalinase and ace
07/02/1998WO1998028412A1 MODIFIED HUMAN FACTOR Xa
07/02/1998WO1998028300A1 Triazolo[4,5-d]pyrimidinyl derivatives and their use as medicaments
07/02/1998WO1998028292A1 Novel piperidine containing compounds
07/02/1998WO1998028282A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
07/02/1998WO1998028269A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS
07/02/1998WO1998028057A1 Biological fluid processing
07/02/1998WO1998028009A1 Pharmaceutical compositions for freeze drying
07/02/1998CA2276034A1 Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors
07/02/1998CA2275796A1 Nitrogen containing heteroaromatics as factor xa inhibitors
07/02/1998CA2271440A1 Biological fluid processing
07/01/1998EP0850648A2 Combination of thrombolytically active proteins and anticoagulants and uses thereof
07/01/1998EP0850251A1 Nitrosated hemoglobins and therapeutic uses therefor
07/01/1998EP0850235A1 Quinolein-2(1h)-one derivatives as serotonin antagonists
07/01/1998EP0850053A1 Erythrocytes loaded with s-nitrosothiol and uses therefor
07/01/1998EP0578728B1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa
07/01/1998CN1186502A Compositions and methods for inhibiting thrombogenesis
07/01/1998CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
07/01/1998CN1186074A New imidazoline compounds, process for preparing them and pharmaceutical compositions containing them
07/01/1998CN1185967A Blood circulation promoting capsule for hemalopia
07/01/1998CN1185961A Capsule for apoplexy
07/01/1998CN1038937C Preparation of ergoline-8-carboxamides
06/1998
06/30/1998US5773612 Indol-2-one derivatives
06/30/1998US5773577 Products comprising substrates capable of enzymatic cross-linking
06/30/1998US5773530 Pyrazolopyridine adenosine antagonists
06/30/1998US5773418 Fibrin monomer or a composition comprising noncrosslinked fibrin is utilized as a component of the fibrin sealant
06/30/1998US5773417 Blood substitutes
06/30/1998US5773411 Cardiovascular disorders and brain disorders and coagulants
06/30/1998US5772992 For therapeutic coadministering of proteins as in hematopoietic reconstitution factors or interleukin variants
06/25/1998WO1998027112A1 Cyclic peptide derivatives
06/25/1998WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
06/25/1998WO1998026781A1 Method of treating or inhibiting neutropenia
06/25/1998WO1998026776A1 Method for treating renal failure
06/25/1998WO1998019649A3 Methods and compositions for inhibition of angiogenesis
06/25/1998WO1998016504A3 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
06/25/1998DE19653036A1 Cyclopeptidderivate Cyclopeptide derivatives
06/25/1998CA2280233A1 Cyclopeptide derivatives
06/25/1998CA2273288A1 Method of treating or inhibiting neutropenia
06/24/1998EP0849361A2 Novel ligands of the neuropeptide receptor HFGAN72
06/24/1998EP0849280A2 Fucans with low molecular weight having anticoagulant, antithrombinic and antithrombotic activity
06/24/1998EP0849261A1 Piperazinophenyl- and piperazinophenyloxy-carboxylic acid derivatives as well as processes and intermediates for their preparation and medicaments containing these compounds
06/24/1998EP0848719A2 Inhibitors of fibrin cross-linking and/or transglutaminases
06/24/1998EP0848708A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants
06/24/1998EP0751785B1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
06/24/1998EP0680468B1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation
06/23/1998US5770727 Crosslinked hemoglobin product comprising tetrameric and oligomeric hemoglobin units
06/23/1998US5770699 Process for production of inhibited forms of activated blood factors
06/23/1998US5770693 Calpain-inhibiting peptide analogs of the kininogen heavy chain
06/23/1998US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with
06/23/1998US5770600 Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors
06/23/1998US5770578 Use of triterpensaponins, such as notoginsenoside R1 (NR1) and/or astragaloside (ASIV) for preparing medicaments
06/23/1998US5770575 Nipecotic acid derivatives as antithrombotic compounds
06/23/1998US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide
06/23/1998US5770425 Human tissue plasminogen activator variants
06/23/1998US5770198 Anticoagulants
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/23/1998US5770194 Fibrin sealant compositions and methods for utilizing same
06/23/1998CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives
06/23/1998CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
06/19/1998CA2225091A1 Piperazinophenyl-and piperazinophenyloxycarboxylic acid derivatives, and processes and intermediates for their preparation and pharmaceutical compositions comprising them
06/18/1998WO1998025970A1 Antithrombotic peptides derived from fibronectin type ii repeats
06/18/1998WO1998025965A2 Peptides and compounds that bind to the thrombopoietin receptor
06/18/1998WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998WO1998025641A1 MEDICAL USES OF scuPA/suPAR COMPLEX
06/18/1998WO1998025611A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
06/18/1998WO1998025601A1 Fibrinogen receptor antagonists
06/18/1998WO1998025457A1 Composition and method for preserving progenitor cells
06/18/1998WO1998016523A3 Selective factor xa inhibitors
06/18/1998WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd
06/18/1998CA2621857A1 Peptides and compounds that bind to a receptor
06/18/1998CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998CA2274477A1 Medical uses of scupa/supar complex
06/18/1998CA2274142A1 Antithrombotic peptides derived from fibronectin type ii repeats
06/18/1998CA2274029A1 Fibrinogen receptor antagonists
06/17/1998EP0848061A2 Self-enhancing, pharmacologically controllable expression systems
06/17/1998EP0689549B1 New urea derivates, their preparation and their use
06/17/1998EP0636142B1 Lactam peptides having hle inhibiting activity
06/17/1998EP0611376B1 Production and use of multimeric hemoglobins
06/17/1998CN1184648A Health-care food oral liquor contg. donkey-hide gelatin, and its prodn. process
06/17/1998CN1184636A Formulation for iron chelation process for preparing formulation
06/17/1998CN1038751C Cyclopeptides
06/17/1998CN1038748C Method for prepn. of sulfonamide fibrinogen receptor antagonists
06/16/1998US5767239 Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of same
06/16/1998US5767115 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
06/16/1998US5767089 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
06/16/1998US5766921 Hybrid protein C
06/16/1998US5766886 Modified antibody variable domains
06/16/1998US5766581 Increasing platelet number with polypeptide molecules attached to polyethylene glycol
06/11/1998WO1998024917A1 Thrombolytic agents with antithrombotic activity
06/11/1998WO1998024908A1 Human chemokine beta-13
06/11/1998WO1998024905A2 Secreted proteins and polynucleotides encoding them
06/11/1998WO1998024884A1 Transgenic non-human animals capable of producing heterologous antibodies
06/11/1998WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024784A1 Substituted sulfonic acid n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
06/11/1998WO1998024782A2 Substituted pyrimidine compounds and their use
06/11/1998WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use
06/11/1998WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity
06/11/1998WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
06/11/1998WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998WO1998017319A3 Platelet substitutes and conjugation methods suitable for their preparation